102 related articles for article (PubMed ID: 21220976)
1. ¹¹C-Methionine or ¹¹C-Choline PET is superior to MRI in the evaluation of gliomatosis cerebri.
Cai L; Gao S; Li Y; Lu D
Clin Nucl Med; 2011 Feb; 36(2):127-9. PubMed ID: 21220976
[TBL] [Abstract][Full Text] [Related]
2. [The PET/CT with 18F-fluorocholine in the diagnosis of gliomatosis cerebri type 2].
Niccoli-Asabella A; Notaristefano A; Garribba MG; Rubini D; Ferrari C; Rubini G
Recenti Prog Med; 2013 Feb; 104(2):73-5. PubMed ID: 23535962
[TBL] [Abstract][Full Text] [Related]
3. Serial positron emission tomography (PET) in gliomatosis cerebri treated with radiotherapy: a case report.
Shintani S; Tsuruoka S; Shiigai T
J Neurol Sci; 2000 Feb; 173(1):25-31. PubMed ID: 10675576
[TBL] [Abstract][Full Text] [Related]
4. Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
Sato N; Inoue T; Tomiyoshi K; Aoki J; Oriuchi N; Takahashi A; Otani T; Kurihara H; Sasaki T; Endo K
Neuroradiology; 2003 Oct; 45(10):700-7. PubMed ID: 13680026
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri.
Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri, imaging findings of 12 cases.
Desclée P; Rommel D; Hernalsteen D; Godfraind C; de Coene B; Cosnard G
J Neuroradiol; 2010 Jul; 37(3):148-58. PubMed ID: 20334921
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging features of canine gliomatosis cerebri.
Schweizer-Gorgas D; Henke D; Oevermann A; Lang J; Vandevelde M; Steffen F
Vet Radiol Ultrasound; 2018 Mar; 59(2):180-187. PubMed ID: 29110365
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of glioblastoma with gliomatosis cerebri growth pattern on diffusion and perfusion MRI.
Förster A; Brehmer S; Seiz-Rosenhagen M; Mildenberger I; Giordano FA; Wenz H; Reuss D; Hänggi D; Groden C
J Neurooncol; 2019 Mar; 142(1):103-109. PubMed ID: 30565029
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
Phi JH; Paeng JC; Lee HS; Wang KC; Cho BK; Lee JY; Park SH; Lee J; Lee DS; Kim SK
J Nucl Med; 2010 May; 51(5):728-34. PubMed ID: 20395328
[TBL] [Abstract][Full Text] [Related]
10. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract][Full Text] [Related]
11. Clinical diagnosis of gliomatosis cerebri: report of three cases.
Akimoto J; Nishioka H; Miki T; Haraoka J; Kudo M
Brain Tumor Pathol; 2004; 21(2):87-95. PubMed ID: 15700839
[TBL] [Abstract][Full Text] [Related]
12. Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.
Georgakis MK; Tsivgoulis G; Spinos D; Dimitriou NG; Kyritsis AP; Herrlinger U; Petridou ET
J Neurooncol; 2018 Nov; 140(2):467-475. PubMed ID: 30117023
[TBL] [Abstract][Full Text] [Related]
13. Teaching neuroimages: FDG-PET imaging in primary diffuse leptomeningeal gliomatosis.
Weijenberg A; van Dijk JM; Pruim J; Luijckx GJ
Neurology; 2013 Oct; 81(16):e119-20. PubMed ID: 24127193
[No Abstract] [Full Text] [Related]
14. [Gliomatosis cerebri. MRI, SPECT and the study of pathology].
Porta-Etessam J; Berbel A; Martínez-Salio A; Balsalobre-Aznar J; Madero S; Ramos A; Vallejo AR
Rev Neurol; 1999 Aug 1-15; 29(3):287-8. PubMed ID: 10797910
[No Abstract] [Full Text] [Related]
15. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
16. [Gliomatosis Cerebri as a Clinical Entity].
Sugiyama K
Brain Nerve; 2017 Jan; 69(1):35-43. PubMed ID: 28126976
[TBL] [Abstract][Full Text] [Related]
17. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
18. Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.
Mineura K; Sasajima T; Kowada M; Uesaka Y; Shishido F
J Nucl Med; 1991 Apr; 32(4):726-8. PubMed ID: 2013813
[TBL] [Abstract][Full Text] [Related]
19. [Gliomatosis cerebri as cause of neuropsychiatric symptoms].
Tikkakoski T; Ostrovska V; Ingo S; Bode MK; Timo K; Tuominen H
Duodecim; 2014; 130(12):1183-7. PubMed ID: 25016665
[TBL] [Abstract][Full Text] [Related]
20. Gliomatosis cerebri involving the lumbosacral spinal cord.
Yaguchi M; Nakasone A; Sohmiya M; Saitoh F; Ohya N; Yoshida T; Nakazato Y; Okamoto K
Intern Med; 2003 Jul; 42(7):615-8. PubMed ID: 12879957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
